Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

July 01, 1992; Volume 20,Issue 4
  • You have access
    Effects of dose, sex, and age on the disposition of alendronate, a potent antiosteolytic bisphosphonate, in rats.
    J H Lin, I W Chen and D E Duggan
    Drug Metabolism and Disposition July 1992, 20 (4) 473-478;
  • You have access
    Metabolism of the leukotriene receptor antagonist 5-(2-(8-phenyloctyl)phenyl)-4,6-dithianonanedioic acid (SK&F 102922) in the guinea pig. Rearrangement of the acyl glucuronide.
    J F Newton, K M Straub, R H Dewey, C D Perchonock, M E McCarthy, J G Gleason and R K Lynn
    Drug Metabolism and Disposition July 1992, 20 (4) 479-484;
  • You have access
    A physiologically based pharmacokinetic model for (-)-quinuclidinyl benzylate using nonlinear irreversible tissue binding parameters in rats.
    J Ishizaki, E Nakashima, K Yokogawa, T Nagano, T Takayasu and F Ichimura
    Drug Metabolism and Disposition July 1992, 20 (4) 485-489;
  • You have access
    Lack of effect of streptogramins on hepatic drug metabolism enzymes in the rat.
    M R Martinet, Y Vedrine, V Piguet and A Frydman
    Drug Metabolism and Disposition July 1992, 20 (4) 490-495;
  • You have access
    Probenecid-impaired biliary excretion of acetaminophen glucuronide and sulfate in the rat.
    P M Savina and K L Brouwer
    Drug Metabolism and Disposition July 1992, 20 (4) 496-501;
  • You have access
    Metabolism of simultaneously administered antipyrine and theophylline in male BN/BiRij rats before and after induction with 3-methylcholanthrene.
    K Groen, D D Breimer and C F van Bezooijen
    Drug Metabolism and Disposition July 1992, 20 (4) 502-506;
  • You have access
    Noninvasive in vivo 13C-NMR spectroscopy in the rat to study the pharmacokinetics of 13C-labeled xenobiotics.
    H J Muller, D Lanens, T J de Cock Buning, F L van de Vyver, F C Alderweireldt, R Dommisse, M Spanoghe, G J Mulder and J Lugtenburg
    Drug Metabolism and Disposition July 1992, 20 (4) 507-509;
  • You have access
    Effects of pregnancy and ethanol treatment on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by hamster liver and lung microsomes.
    R Jorquera, A Castonguay and H M Schuller
    Drug Metabolism and Disposition July 1992, 20 (4) 510-517;
  • You have access
    Dominant role of cytochrome P-450 2E1 in human hepatic microsomal oxidation of the CFC-substitute 1,1,1,2-tetrafluoroethane.
    S E Surbrook and M J Olson
    Drug Metabolism and Disposition July 1992, 20 (4) 518-524;
  • You have access
    Tissue distribution and lung localization of [14C]azelastine in guinea pigs.
    K K Wong, J T Yang, N Kucharczyk and R D Sofia
    Drug Metabolism and Disposition July 1992, 20 (4) 525-529;
  • You have access
    Pharmacokinetics of azelastine and its active metabolite, desmethylazelastine, in guinea pigs.
    V E Adusumalli, K K Wong, N Kucharczyk and R D Sofia
    Drug Metabolism and Disposition July 1992, 20 (4) 530-535;
  • You have access
    Metabolism of [14C]azelastine in guinea pigs.
    J T Yang, K K Wong, N Kucharczyk and R D Sofia
    Drug Metabolism and Disposition July 1992, 20 (4) 536-540;
  • You have access
    Total body and hepatic clearance in rats of recombinant tissue-type plasminogen activator expressed in mouse C127 and Chinese hamster ovary cells.
    R Hori, Y L He, T Shima, K Inui, S Aoki, K Okumura and Y Tanigawara
    Drug Metabolism and Disposition July 1992, 20 (4) 541-546;
  • You have access
    Effects of low-density lipoprotein and ethinyl estradiol on cyclosporine metabolism in isolated rat liver perfusions.
    T Prueksaritanont, B A Hoener and L Z Benet
    Drug Metabolism and Disposition July 1992, 20 (4) 547-552;
  • You have access
    Tissue disposition of glyceryl trinitrate, 1,2-glyceryl dinitrate, and 1,3-glyceryl dinitrate in tolerant and nontolerant rats.
    K E Torfgård, J Ahlner, K L Axelsson, B Norlander and A Bertler
    Drug Metabolism and Disposition July 1992, 20 (4) 553-558;
  • You have access
    Correlation between N-acetyltransferase activities in uroepithelia and in vivo acetylator phenotype.
    J C Pink, E M Messing, C A Reznikoff, G T Bryan and S Swaminathan
    Drug Metabolism and Disposition July 1992, 20 (4) 559-565;
  • You have access
    12 alpha-hydroxytestosterone. A hitherto unidentified testosterone metabolite produced by cytochrome P-450 2A2.
    S J Smith, K R Korzekwa, T Aoyama, F J Gonzalez, J F Darbyshire, K Sugiyama and J R Gillette
    Drug Metabolism and Disposition July 1992, 20 (4) 566-571;
  • You have access
    Effect of miconazole on warfarin disposition in rabbits.
    A P D'Mello, R V Venkataramanan and T R Bates
    Drug Metabolism and Disposition July 1992, 20 (4) 572-577;
  • You have access
    3'-azido-3'-deoxythymidine drug interactions. Screening for inhibitors in human liver microsomes.
    J F Rajaonarison, B Lacarelle, J Catalin, M Placidi and R Rahmani
    Drug Metabolism and Disposition July 1992, 20 (4) 578-584;
  • You have access
    Pharmacokinetic analysis of enterohepatic circulation of 4-[2-(4-isopropylbenzamido)ethoxy]benzoic acid. Effect of intramolecular rearrangement of its acyl glucuronide.
    H Komura, H Fukui, H Sasaki and A Morino
    Drug Metabolism and Disposition July 1992, 20 (4) 585-591;
  • You have access
    Pharmacokinetics and tissue distribution of human urinary tumor necrosis factor binding protein in mice.
    M P Gascon, H C Porchet, J Y Le Cotonnec, A Ythier, D Wallach, P F Piguet and G E Grau
    Drug Metabolism and Disposition July 1992, 20 (4) 592-595;
  • You have access
    Identification of urinary metabolites of 8-methyl-8-azabicyclo- 3,2,1] octan-3-yl 3,5-dichlorobenzoate (MDL 72,222) in the dog and monkey.
    W P Gordon, H Cheng, D L Larsen, J A Ragner and N G Landmesser
    Drug Metabolism and Disposition July 1992, 20 (4) 596-602;
  • You have access
    Pharmacokinetics and metabolism of the 5-hydroxytryptamine antagonist tropisetron after single oral doses in humans.
    V Fischer, J P Baldeck and F L Tse
    Drug Metabolism and Disposition July 1992, 20 (4) 603-607;
  • You have access
    Renal handling of alendronate in rats. An uncharacterized renal transport system.
    J H Lin, I W Chen, F A Deluna and M Hichens
    Drug Metabolism and Disposition July 1992, 20 (4) 608-613;
  • You have access
    Phenol sulfotransferase activity in rat liver parenchymal cells cultured on collagen gels.
    D Utesch and F Oesch
    Drug Metabolism and Disposition July 1992, 20 (4) 614-615;
  • You have access
    Metabolism of alachlor by rat and monkey liver and nasal turbinate tissue.
    A A Li, K J Asbury, W E Hopkins, P C Feng and A G Wilson
    Drug Metabolism and Disposition July 1992, 20 (4) 616-618;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 20, Issue 4
1 Jul 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics